Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DoseID Consortium, now branded as UnitVisID Alliance, is a member-driven healthcare industry alliance focused on standardizing and certifying RFID use for pharmaceutical products across the supply chain. Rather than developing therapeutics, the organization provides specifications, registry infrastructure, certification frameworks, and interoperability standards to help manufacturers, hospitals, pharmacies, and technology vendors track RFID-tagged medications from production through patient use. Its work is aimed at improving medication visibility, inventory management, recall execution, workflow efficiency, and patient safety in hospital and pharmacy settings. The alliance appears to operate as an active healthcare technology and standards body rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DoseID Consortium.